An Overview of Hypoglycemic Traditional Drugs
Author:
Chen Haixia,Li Nannan
Publisher
Springer Singapore
Reference115 articles.
1. Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Mirchov IB, Ben-Nakhi A, Reaven G, Sambo BH, Mendis S, Roglic G (2010) The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 53(4):600–605. https://doi.org/10.1007/s00125-009-1620-4 2. Tang YZ, Wang G, Jiang ZH, Yan TT, Chen YJ, Yang M, Meng LL, Zhu YJ, Li CG, Li Z, Yu P, Ni CL (2015) Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent. Diabetol Metab Syndr 7:9. https://doi.org/10.1186/s13098-015-0087-3 3. Xiao SW, Liu C, Chen MJ, Zou JF, Zhang ZM, Cui X, Jiang S, Shang EX, Qian DW, Duan JN (2020) Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites. Appl Microbiol Biot 104(1):303–317. https://doi.org/10.1007/s00253-019-10174-w 4. Bannister M, Berlanga J (2016) Effective utilization of oral hypoglycemic agents to achieve individualized HbA1c targets in patients with type 2 diabetes mellitus. Diab Therapy 7(3):387–399. https://doi.org/10.1007/s13300-016-0188-5 5. Mishra GP, Sharma R (2016) Identification of potential PPAR gamma agonists as hypoglycemic agents: molecular docking approach. Interdiscip Sci 8(3):220–228. https://doi.org/10.1007/s12539-015-0126-7
|
|